Nyxoah (NYXH) News Today $6.10 +0.09 (+1.50%) Closing price 05/2/2025 04:00 PM EasternExtended Trading$6.09 -0.01 (-0.16%) As of 05/2/2025 07:20 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Headlines Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsHeadlinesOwnershipSEC FilingsShort InterestTrendsBuy This Stock All Sources Trusted Sources MarketBeat Benzinga Bloomberg GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha TalkMarkets The Street TipRanks The Wall Street Journal Wall Street Zen Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent May 2025 April 2025 March 2025 February 2025 January 2025 December 2024 November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 September 2022 August 2022 July 2022 June 2022 Time Period INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Nyxoah S.A. - NYXHApril 29, 2025 | globenewswire.comINVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Nyxoah S.A. - NYXHApril 28, 2025 | prnewswire.comINVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Nyxoah S.A. - NYXHApril 25, 2025 | gurufocus.comINVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Nyxoah S.A. - NYXHApril 25, 2025 | globenewswire.comStifel Nicolaus Cuts Nyxoah (NASDAQ:NYXH) Price Target to $14.00Stifel Nicolaus reduced their target price on shares of Nyxoah from $15.00 to $14.00 and set a "buy" rating on the stock in a report on Monday.April 23, 2025 | marketbeat.comINVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Nyxoah S.A. - NYXHApril 22, 2025 | prnewswire.comShort Interest in Nyxoah S.A. (NASDAQ:NYXH) Expands By 164.1%Nyxoah S.A. (NASDAQ:NYXH - Get Free Report) was the recipient of a large increase in short interest during the month of March. As of March 31st, there was short interest totalling 168,200 shares, an increase of 164.1% from the March 15th total of 63,700 shares. Based on an average daily trading volume, of 106,100 shares, the short-interest ratio is currently 1.6 days. Approximately 1.1% of the shares of the company are sold short.April 17, 2025 | marketbeat.comConditional Issuance of SharesApril 16, 2025 | globenewswire.comINVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Nyxoah S.A. - NYXHApril 14, 2025 | prnewswire.comBronstein, Gewirtz & Grossman, LLC Is Investigating Nyxoah S.A. (NYXH) And Encourages Investors to ConnectApril 13, 2025 | markets.businessinsider.comINVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Nyxoah S.A. - NYXHApril 12, 2025 | gurufocus.comKepler Capital Sticks to Its Buy Rating for Nyxoah (NYXH)April 10, 2025 | markets.businessinsider.comNyxoah (NASDAQ:NYXH) Given "Buy" Rating at HC WainwrightHC Wainwright reaffirmed a "buy" rating and set a $15.00 target price on shares of Nyxoah in a report on Tuesday.April 10, 2025 | marketbeat.comNyxoah anticipates FDA approval for Genio system in Q2April 8, 2025 | markets.businessinsider.comINVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Nyxoah S.A. - NYXHApril 8, 2025 | prnewswire.comNyxoah Provides Update on FDA Approvable Letter for Genio SystemApril 8, 2025 | globenewswire.comINVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Nyxoah S.A. - NYXHApril 7, 2025 | globenewswire.comNYXH Investors Have Opportunity to Join Nyxoah S.A. Fraud Investigation with the Schall Law FirmApril 7, 2025 | prnewswire.comNYXH Investors Have Opportunity to Join Nyxoah S.A. Fraud Investigation with the Schall Law FirmApril 5, 2025 | gurufocus.comNYXH Investors Have Opportunity to Join Nyxoah S.A. Fraud Investigation with the Schall Law FirmApril 5, 2025 | businesswire.comINVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Nyxoah S.A. - NYXHApril 3, 2025 | globenewswire.comNyxoah S.A. Investors: Company Investigated by the Portnoy Law FirmMarch 31, 2025 | globenewswire.comINVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Nyxoah S.A. - NYXHMarch 31, 2025 | prnewswire.comShort Interest in Nyxoah S.A. (NASDAQ:NYXH) Declines By 36.4%Nyxoah S.A. (NASDAQ:NYXH - Get Free Report) was the target of a large decline in short interest in March. As of March 15th, there was short interest totalling 63,700 shares, a decline of 36.4% from the February 28th total of 100,200 shares. Currently, 0.4% of the shares of the company are sold short. Based on an average daily trading volume, of 47,400 shares, the short-interest ratio is presently 1.3 days.March 30, 2025 | marketbeat.comKepler Capital Remains a Buy on Nyxoah (NYXH)March 29, 2025 | markets.businessinsider.comHC Wainwright Analysts Boost Earnings Estimates for NyxoahNyxoah S.A. (NASDAQ:NYXH - Free Report) - Equities research analysts at HC Wainwright raised their Q1 2025 earnings per share (EPS) estimates for Nyxoah in a research note issued to investors on Wednesday, March 26th. HC Wainwright analyst E. White now expects that the company will post earningsMarch 29, 2025 | marketbeat.comStifel Nicolaus Sticks to Its Buy Rating for Nyxoah (NYXH)March 28, 2025 | markets.businessinsider.comNyxoah S.A. Being Investigated on Behalf of Nyxoah S.A. Investors. Contact Levi & Korsinsky For DetailsMarch 27, 2025 | markets.businessinsider.comNyxoah (NASDAQ:NYXH) Price Target Lowered to $15.00 at HC WainwrightHC Wainwright dropped their price target on shares of Nyxoah from $17.00 to $15.00 and set a "buy" rating on the stock in a research note on Wednesday.March 27, 2025 | marketbeat.comNyxoah announces FDA approvable letter for Genio pre-market approval applicationMarch 27, 2025 | markets.businessinsider.comNyxoah price target lowered to $15 from $17 at H.C. WainwrightMarch 27, 2025 | markets.businessinsider.comFDA Issues Nyxoah an Approvable Letter for its Genio® SystemMarch 26, 2025 | globenewswire.comNyxoah files $200M mixed securities shelfMarch 21, 2025 | markets.businessinsider.comNyxoah S.A. (NASDAQ:NYXH) Sees Large Growth in Short InterestNyxoah S.A. (NASDAQ:NYXH - Get Free Report) was the target of a large increase in short interest during the month of February. As of February 28th, there was short interest totalling 100,200 shares, an increase of 27.2% from the February 13th total of 78,800 shares. Based on an average daily trading volume, of 43,000 shares, the days-to-cover ratio is currently 2.3 days. Currently, 0.7% of the company's stock are sold short.March 18, 2025 | marketbeat.comAnalysts Are Bullish on Top Healthcare Stocks: Nyxoah (NYXH), Sandoz Group Ltd (SDZXF)March 15, 2025 | markets.businessinsider.comNyxoah (NASDAQ:NYXH) Price Target Cut to $15.00 by Analysts at Stifel NicolausStifel Nicolaus reduced their price target on Nyxoah from $16.00 to $15.00 and set a "buy" rating on the stock in a research report on Friday.March 15, 2025 | marketbeat.comNyxoah price target lowered to $15 from $16 at StifelMarch 14, 2025 | markets.businessinsider.comNyxoah S.A. (NASDAQ:NYXH) Q4 2024 Earnings Call TranscriptMarch 14, 2025 | msn.comNyxoah (NASDAQ:NYXH) Releases Quarterly Earnings ResultsNyxoah (NASDAQ:NYXH - Get Free Report) released its quarterly earnings results on Thursday. The company reported ($0.49) earnings per share for the quarter, missing the consensus estimate of ($0.46) by ($0.03). Nyxoah had a negative return on equity of 51.68% and a negative net margin of 1,043.93%.March 14, 2025 | marketbeat.comNyxoah reports Q4 revenue EUR 1.3MMarch 13, 2025 | markets.businessinsider.comNyxoah SA (NYXH) Q4 2024 Earnings Call TranscriptMarch 13, 2025 | seekingalpha.comEQS-News: Nyxoah Reports Fourth Quarter and Financial Year 2024 Financial and Operating ResultsMarch 13, 2025 | markets.businessinsider.comNyxoah Reports Fourth Quarter and Financial Year 2024 Financial and Operating ResultsMarch 13, 2025 | globenewswire.comNyxoah to Release Fourth Quarter and Financial Year 2024 Financial Results on March 13, 2025March 10, 2025 | globenewswire.comNyxoah (NYXH) to Release Quarterly Earnings on ThursdayNyxoah (NASDAQ:NYXH) will be releasing earnings after the market closes on Thursday, March 13.March 6, 2025 | marketbeat.comNyxoah to Participate in the Oppenheimer 35th Annual Healthcare MedTech & Services ConferenceMarch 3, 2025 | globenewswire.comNyxoah (NYXH) to Release Earnings on TuesdayNyxoah (NASDAQ:NYXH) will be releasing earnings before the market opens on Tuesday, March 4, Financial Modeling Prep reports.February 25, 2025 | marketbeat.comNyxoah announces commercial launch of Genio system in the Middle EastFebruary 19, 2025 | markets.businessinsider.comNyxoah Announces Commercial Launch of Genio® Breakthrough Therapy in the Middle EastFebruary 19, 2025 | globenewswire.comNyxoah Announces Commercial Launch of Genio® Breakthrough Therapy in the Middle EastFebruary 19, 2025 | globenewswire.com Get Nyxoah News Delivered to You Automatically Sign up to receive the latest news and ratings for NYXH and its competitors with MarketBeat's FREE daily newsletter. Email Address NYXH Media Mentions By Week NYXH Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. NYXH News Sentiment▼0.000.58▲Average Medical News Sentiment NYXH News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. NYXH Articles This Week▼22▲NYXH Articles Average Week Get Nyxoah News Delivered to You Automatically Sign up to receive the latest news and ratings for NYXH and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies AxoGen News Today Embecta News Today Iradimed News Today SI-BONE News Today Bioventus News Today RxSight News Today Butterfly Network News Today Avanos Medical News Today CeriBell News Today OrthoPediatrics News Today Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:NYXH) was last updated on 5/3/2025 by MarketBeat.com Staff From Our PartnersThink NVDA’s run was epic? You ain’t seen nothin’ yetAsk most investors and they’ll probably tell you Nvidia is the undisputed AI stock of the decade. In 2023, ...Timothy Sykes | SponsoredElon’s Terrifying Warning Forces Trump To Take ActionElon Musk has avoided two major financial crises before. He pulled Tesla and SpaceX back from the brink of col...American Hartford Gold | SponsoredTrump’s Bitcoin Reserve is No Accident…Bryce Paul believes this is the #1 coin to buy right now The catalyst behind this surge is a massive new b...Crypto 101 Media | SponsoredElon Set to Shock the World by May 1st ?Tech legend Jeff Brown recently traveled to the industrial zone of South Memphis to investigate what he believ...Brownstone Research | SponsoredGold Alert: The Truth About Fort Knox Is ComingOwning physical gold isn’t the best way to profit. I’ve found a better way to invest in gold—one that’s alr...Golden Portfolio | SponsoredWhat President Trump’s Executive Order 14154 means for your moneyNearly $3 trillion disappeared from the stock market on Thursday morning. According to Whitney Tilson - a f...Stansberry Research | SponsoredHow to invest in Elon Musk’s Optimus before its launchElon Musk is set to completely take over the AI industry with Optimus… A breakthrough AI-powered robot that El...InvestorPlace | SponsoredMost traders are panicking. We’re cashing inMost traders are panicking right now. Bitcoin’s dropping. Altcoins are bleeding. The stock market’s a mess....Crypto Swap Profits | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Nyxoah S.A. Please log in to your account or sign up in order to add this asset to your watchlist. Share Nyxoah With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.